Literature DB >> 23070399

Notch signaling regulates PD-1 expression during CD8(+) T-cell activation.

Mélissa Mathieu1, Natacha Cotta-Grand, Jean-François Daudelin, Paméla Thébault, Nathalie Labrecque.   

Abstract

Programmed cell death 1 (PD-1) is an inhibitory receptor involved in T-cell activation, tolerance and exhaustion. Little is known on how the expression of PD-1 is controlled during T-cell activation. Recent studies demonstrated that NFATc1 and IRF9 regulate Pdcd1 (PD-1) transcription and that T-bet acts as a transcriptional repressor. In this study, we have investigated the role of the Notch signaling pathway in PD-1 regulation. Using specific inhibitors of the Notch signaling pathway, we showed decreased PD-1 expression and inhibition of Pdcd1 transcription by activated CD8(+) T cells. Chromatin immunoprecipitation further showed occupancy of the Pdcd1 promoter with RBPJk and Notch1 intracellular domain at RBPJk-binding sites. Our results identify the Notch signaling pathway as an important regulator of PD-1 expression by activated CD8(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23070399     DOI: 10.1038/icb.2012.53

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  50 in total

1.  Myeloid-derived suppressor cells impair alveolar macrophages through PD-1 receptor ligation during Pneumocystis pneumonia.

Authors:  Guang-Sheng Lei; Chen Zhang; Chao-Hung Lee
Journal:  Infect Immun       Date:  2014-11-17       Impact factor: 3.441

Review 2.  Transcriptional and epigenetic regulation of PD-1 expression.

Authors:  Zengde Chi; Yan Lu; Yinlong Yang; Bingqing Li; Peiyuan Lu
Journal:  Cell Mol Life Sci       Date:  2021-03-18       Impact factor: 9.261

3.  A genomic variant in IRF9 is associated with serum cytokine levels in pig.

Authors:  Wenwen Wang; Yang Liu; Haifei Wang; Xiangdong Ding; Jianfeng Liu; Ying Yu; Qin Zhang
Journal:  Immunogenetics       Date:  2015-10-31       Impact factor: 2.846

4.  Prolonged PD1 Expression on Neonatal Vδ2 Lymphocytes Dampens Proinflammatory Responses: Role of Epigenetic Regulation.

Authors:  Haoting Hsu; Sarah Boudova; Godfrey Mvula; Titus H Divala; Randy G Mungwira; Christopher Harman; Miriam K Laufer; C David Pauza; Cristiana Cairo
Journal:  J Immunol       Date:  2016-07-29       Impact factor: 5.422

5.  The transcription factor NFAT promotes exhaustion of activated CD8⁺ T cells.

Authors:  Gustavo J Martinez; Renata M Pereira; Tarmo Äijö; Edward Y Kim; Francesco Marangoni; Matthew E Pipkin; Susan Togher; Vigo Heissmeyer; Yi Chen Zhang; Shane Crotty; Edward D Lamperti; K Mark Ansel; Thorsten R Mempel; Harri Lähdesmäki; Patrick G Hogan; Anjana Rao
Journal:  Immunity       Date:  2015-02-10       Impact factor: 31.745

Review 6.  Investigational PD-1 inhibitors in HL and NHL and biomarkers for predictors of response and outcome.

Authors:  Andres Chang; Danielle Schlafer; Christopher R Flowers; Pamela B Allen
Journal:  Expert Opin Investig Drugs       Date:  2017-12-24       Impact factor: 6.206

Review 7.  BET proteins in abnormal metabolism, inflammation, and the breast cancer microenvironment.

Authors:  Guillaume P Andrieu; Jordan S Shafran; Jude T Deeney; Kishan R Bharadwaj; Annapoorni Rangarajan; Gerald V Denis
Journal:  J Leukoc Biol       Date:  2018-03-01       Impact factor: 4.962

8.  Glucocorticoids potentiate the inhibitory capacity of programmed cell death 1 by up-regulating its expression on T cells.

Authors:  Natsumi Maeda; Takumi Maruhashi; Daisuke Sugiura; Kenji Shimizu; Il-Mi Okazaki; Taku Okazaki
Journal:  J Biol Chem       Date:  2019-11-13       Impact factor: 5.157

Review 9.  Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family.

Authors:  Frank A Schildberg; Sarah R Klein; Gordon J Freeman; Arlene H Sharpe
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

Review 10.  Genetic and Epigenetic Regulation of PD-1 Expression.

Authors:  Alexander P R Bally; James W Austin; Jeremy M Boss
Journal:  J Immunol       Date:  2016-03-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.